Thomas Herzog , David O'Malley , John Liao , Karen Finkelstein , Lyndsay Willmott , John Moroney , Joseph Buscema , Katie Campbell-Simms , Susan Zweizig
{"title":"afuresertib联合紫杉醇与紫杉醇治疗铂耐药卵巢癌的疗效和安全性:开放标签随机主动对照II期临床研究(GOG-3044)","authors":"Thomas Herzog , David O'Malley , John Liao , Karen Finkelstein , Lyndsay Willmott , John Moroney , Joseph Buscema , Katie Campbell-Simms , Susan Zweizig","doi":"10.1016/j.ygyno.2025.03.059","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":"200 ","pages":"Page 8"},"PeriodicalIF":4.1000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer: An open-label randomized active-controlled phase II clinical study (GOG-3044)\",\"authors\":\"Thomas Herzog , David O'Malley , John Liao , Karen Finkelstein , Lyndsay Willmott , John Moroney , Joseph Buscema , Katie Campbell-Simms , Susan Zweizig\",\"doi\":\"10.1016/j.ygyno.2025.03.059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":\"200 \",\"pages\":\"Page 8\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825825001726\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825825001726","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer: An open-label randomized active-controlled phase II clinical study (GOG-3044)
期刊介绍:
Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.
Research Areas Include:
• Cell and molecular biology
• Chemotherapy
• Cytology
• Endocrinology
• Epidemiology
• Genetics
• Gynecologic surgery
• Immunology
• Pathology
• Radiotherapy